Menu

Mice Develop with Human Stem Cells

Human embryonic stem cells and induced pluripotent stem cells participated normally in early mouse embryo development in a recent study.

Dec 21, 2015
Karen Zusi

WIKIMEDIA, BO LIInjecting stem cells into mouse embryos is standard practice to examine how well the cells incorporate and aid in tissue development, but previous attempts to get human stem cells to contribute normally to embryo development have failed. Reporting in Cell Stem Cell last week (December 17), researchers from the University of Cambridge successfully implanted human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) into developing mouse embryos and observed them becoming all types of tissue layers.

The University of Cambridge-based authors suggest that their recent success comes from their decision to inject the stem cells at a later stage of embryo development. The hiPSCs and hESCs “have the capacity to participate in normal mouse development when transplanted into gastrula-stage embryos,” they wrote in their study.

The human stem cells differentiated into each of the three primary tissue layers—endoderm, ectoderm, and mesoderm—of the developing mouse. The researchers found no difference between the differentiation abilities of hiPSCs and hESCs. “We conclude that transplanted [human pluripotent stem cells] and their progeny proliferate and contribute normally to the developing embryo, irrespective of transplant stage, site, or cell type,” the authors wrote.

The mouse embryos were cultured for two days, not long enough for differentiation into final tissue types—but the embryos appeared normal during this time period. “The Cambridge team has shown definitively that when stem cells are introduced into early mouse embryos under the right conditions, they multiply and contribute in the correct way to all the cell types that are formed as the embryo develops,” Jeremy Pearson, Associate Medical Director at the British Heart Foundation, which helped fund the study, said in a press release.

“Our finding that human stem cells integrate and develop normally in the mouse embryo will allow us to study aspects of human development during a window in time that would otherwise be inaccessible,” study coauthor Victoria Mascetti said in the press release.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.